Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mucommune logo — Advancing Innovations to Promote Female Reproductive Health

Mucommune

Advancing Innovations to Promote Female Reproductive Health

Founded 2015 United States Morrisville, United States 8 employees Grant Total: $36.53K Biotechnology, Pharmaceutical

General Information

Company Name Mucommune
Founded Year 2015
Location United States Morrisville, United States +1
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

Get notified when Mucommune moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mucommune

Mucommune is a biotechnology and pharmaceutical startup based in the United States. Founded in 2015, the company is dedicated to advancing innovations to promote female reproductive health through a first-in-class platform. The platform focuses on harnessing the synergy between antibodies and mucus to reinforce the mucus barrier for mucosal health. The company has developed proprietary intravaginal ring technologies that enable sustained delivery of small molecules to biomacromolecules, ensuring unparalleled safety from topical delivery. This approach represents a significant advancement in the field of reproductive health. In February 2021, Mucommune secured a $36.53K grant investment from the One North Carolina Small Business Program, signaling recognition and support for its groundbreaking work. This investment will likely bolster the company's research and development efforts, as well as its market penetration within the female reproductive health industry.

Taxonomy: reproductive health, female health, innovations, antibodies, mucus barrier, intravaginal ring, sustained delivery, biomacromolecules, topical delivery

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 02 Feb 2021

Mucommune Alternatives & Competitors

Mucommune vs
AlgiPharma AS
AlgiPharma AS Norway

A biopharmaceutical company with a focus on developing its first drug candidate for patients with Cy...

8 employees
Biotechnology, Pharmaceutical
Mucommune vs
Shecare
Shecare

Helping women manage reproductive health by naturally predicting ovulation through biomarkers such a...

Angel
Health Care, Medical Devices
Mucommune vs
AscorLab
AscorLab

AscorLab introduces a method of mucus collection utilizing only natural processes. Through AscorLab'...

Seed
Biotechnology

FAQ About Mucommune

Advancing Innovations to Promote Female Reproductive Health
Mucommune was founded in 2015.
Mucommune is headquartered in Morrisville, United States.
Mucommune operates in the following industries: Biotechnology, Pharmaceutical.
Mucommune has approximately 8 employees.
Mucommune has completed 1 funding round, raising a total of $36.53K. The latest funding stage is Grant.
Top alternatives and competitors to Mucommune include AlgiPharma AS, Shecare, AscorLab, A-Mansia Biotech, Inhalon Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mucommune and AlgiPharma AS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mucommune and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy